In the context of malignant pleural mesothelioma (MPM), a devastating disease resulting from exposure to asbestos, FAP expression on reactive tumor-associated fibroblasts makes it an attractive target for adoptive T-cell therapy using CARs (Schuberth et al.2013). The gene discussed is FAP; the disease is neoplasm.